Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
DOVATO 50 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Tablet
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- DOLUTEGRAVIR SODIO — 50 mg
- LAMIVUDINA — 300 mg
- Pharmaceutical form Home Med Cabinet grouping
- Tablet
- Availability in Spain
- All 2 packs marketed
Packs
DOVATO 50 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, Frasco de 30 comprimidos
30 pcs
National code
Marketed726336Strength of this pack 50 mg
DOVATO 50 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, Blíster de 30 comprimidos
30 pcs
National code
Marketed763454Strength of this pack 50 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 1191370001Official data
- Marketing authorisation holder
- VIIV HEALTHCARE B.V.Official data
- Authorised
- Jul 19, 2019Official data
- Authority form code
- 42Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.